Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells.
It has been demonstrated that human osteoblastic as well as osteoclastic cells are equipped with adrenergic receptors and neuropeptide receptors and that they constitutively express diffusible axon guidance molecules that are known to function as a chemoattractant and/or chemorepellent for growing nerve fibers. These findings suggest that the extension of axons of sympathetic and peripheral sensory neurons to osteoblastic and osteoclastic cells is required for the dynamic neural regulation of local bone metabolism. Recently, bone resorption modulated by sympathetic stimulation was demonstrated to be associated with ODF (osteoclast differentiation factor) and OCIF (osteoclastogenesis inhibitory factor) produced by osteoblasts/stromal cells. This review summarizes the evidence implicating sympathetic neuron action in bone metabolism. The possible function of osteoclastogenesis, which could result in the initiation of sympathomimetic bone resorption, is also discussed.
Department of Pharmacology, School of Dentistry, Aichi-Gakuin University, Nagoya 464-8650, Japan. togariaf@dpc.aichi-gakuin.ac.jp
Akifumi
A
Togari
D001369:Axons / Q000502:physiology*; D001862:Bone Resorption; D001842:Bone and Bones / Q000502:physiology*; D004837:Epinephrine / Q000378:metabolism; D006801:Humans; D010006:Osteoblasts / Q000502:physiology*; D010010:Osteoclasts / Q000502:physiology*; D011941:Receptors, Adrenergic / Q000378:metabolism; D018013:Receptors, Neuropeptide / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000502:physiology*
D011941:Receptors, Adrenergic; D018013:Receptors, Neuropeptide; D004837:Epinephrine